SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 40 filers reported holding SINOVAC BIOTECH LTD in Q4 2013. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $0 | – | 89 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 89 | -91.1% | 0.00% | – |
| Q1 2015 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $6,000 | -57.1% | 1,000 | -50.0% | 0.00% | 0.0% |
| Q1 2014 | $14,000 | +133.3% | 2,000 | +100.0% | 0.00% | 0.0% |
| Q4 2013 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $6,000 | +50.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $4,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,000,000 | 7.22% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.18% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.82% |
| Financial Gravity Asset Management, Inc. | 988 | $3,197,686 | 0.04% |
| Yorktown Management & Research Co Inc | 149,786 | $4,494 | 0.01% |
| Renaissance Technologies | 2,375,841 | $1,537 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,661 | $10,747 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $2,666 | 0.00% |